InMode (INMD) Income from Continuing Operations (2018 - 2026)
InMode (INMD) posted Income from Continuing Operations of 11562000.0 for Q1 2026, down 67.49% sequentially from 35559000.0 in Q4 2025, and down 36.48% YoY from 18201000.0 in Q1 2025.
InMode (INMD) Income from Continuing Operations (2018 - 2026) Analysis & Trends
InMode has reported Income from Continuing Operations for 9 years, with the latest figure at 11562000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 36.48% year-over-year to 11562000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 95726000.0 (up 28.22% YoY) and the FY2025 annual result came in at 126829000.0, up 20.03% from the prior year.
- Income from Continuing Operations retreated to 11562000.0 in Q1 2026 per INMD's latest filing, from 35559000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 65163000.0 in Q4 2023 and troughed at 18351000.0 in Q4 2024.
- A 5-year average of 33530705.88 and a median of 35559000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations sank 128.16% in 2024, then jumped 293.77% in 2025.
- Over 5 years, Income from Continuing Operations stood at 37708000.0 in 2022, then jumped by 72.81% to 65163000.0 in 2023, then plunged by 128.16% to 18351000.0 in 2024, then surged by 293.77% to 35559000.0 in 2025, then plunged by 67.49% to 11562000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 11562000.0, 35559000.0, and 21863000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 201.00 Mn |
| 10 | InMode | 911.60 Mn | 496.43 Mn | 71.52 Mn | 17.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.56 Mn |
| Dec 31, 2025 | 35.56 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.74 Mn |
| Mar 31, 2025 | 18.20 Mn |
| Dec 31, 2024 | -18.35 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 23.82 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | 65.16 Mn |
| Sep 30, 2023 | 46.52 Mn |
| Jun 30, 2023 | 62.23 Mn |
| Mar 31, 2023 | 40.51 Mn |
| Dec 31, 2022 | 37.71 Mn |
| Sep 30, 2022 | 48.79 Mn |
| Jun 30, 2022 | 44.05 Mn |
| Mar 31, 2022 | 30.98 Mn |
| Dec 31, 2021 | 52.69 Mn |
| Sep 30, 2021 | 44.72 Mn |
| Jun 30, 2021 | 40.93 Mn |